What is it about?
This review discusses the newer drug therapies that were studied and are being evaluated for the management of decompensated heart failure
Featured Image
Why is it important?
The treating clinician should be aware of the progress in the field of heart failure and what to expect in the near future
Read the Original
This page is a summary of: Advances in chemical pharmacotherapy for managing acute decompensated heart failure, Expert Opinion on Pharmacotherapy, March 2017, Taylor & Francis,
DOI: 10.1080/14656566.2017.1299708.
You can read the full text:
Contributors
The following have contributed to this page
